Nattika Nimmano

Dr. Nattika Nimmano


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Nanotechnology, Science and Applications
Verified
Journal Article
Open access
PDF file
STSuradwadee Thungmungmee
Suradwadee Thungmungmee
BSBoonchoo Sritularak
Boonchoo Sritularak
NWNakuntwalai Wisidsri
Nakuntwalai Wisidsri
NKNattakan Kanana
Nattakan Kanana
NNNattika Nimmano
Nattika Nimmano
Purpose: The study aimed to investigate in vitro anti-aging activities of 29 Dendrobium spp. and develop and characterize microemulsions (MEs) for topical application. Methods: Antioxidant activity was determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH), H2O2 scavenging, and ferric reducing antioxidant power (FRAP) assays. The anti-collagenase (MMP-1 and MMP-2) and anti-elastase activities were also evaluated. Cytotoxicity and human intracellular reactive oxygen species (ROS) levels were determined using resazurin reduction and 2′,7′-dichlorofluorescin diacetate (DCFDA) assays, respectively. D. kentrophyllum extract-loaded microemulsion (DKME) was then prepared and optimized. The stability of DKME was studied using a heating-cooling cycle. Results: D. kentrophyllum appeared to be the best candidate anti-aging agent because of its antioxidant, anti-collagenase, and anti-elastase activities. The extract was safe for human skin cells at a concentration of 6.25– 100 μg/mL. It also decreased the intracellular ROS-induced ultraviolet B (UVB) irradiation compared to that in the control. DKME comprising Tween 80:ethanol (5:1), water, and isononyl isononanoate showed a suitable appearance, droplet size, polydisperse index, zeta potential, pH, and viscosity. This formulation demonstrated desirable physical and chemical stability, with non-cytotoxic effects. Conclusion: DKME is considered a promising anti-aging product. However, an in vivo study of this optimized formulation might be evaluated in further study for anti-aging purposes.

16 February 2026 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
NLNandar Tint Lwin
Nandar Tint Lwin
TSThanarat Salahong
Thanarat Salahong
WPWongsakorn Phongsopitanun
Wongsakorn Phongsopitanun
PSParanee Sripreechasak
Paranee Sripreechasak
CCChatchai Chaotham
Chatchai Chaotham
NNNattika Nimmano
Nattika Nimmano
Clausena excavataBurm. f. (Rutaceae), a tropical plant widely used in traditional medicine, contains bioactive compounds, including essential oils with ant

10 August 2026 in ACS Omega
Verified
Journal Article
Open access
KNKhin Cho Nyein
Khin Cho Nyein
MGMaxius Gunawan
Maxius Gunawan
PMPapon Muangsanit
Papon Muangsanit
SASudartip Areecheewakul
Sudartip Areecheewakul
JCJittima Chatchawalsaisin
Jittima Chatchawalsaisin
NNNattika Nimmano
Nattika Nimmano
Non-small cell lung cancer (NSCLC), the most common subtype of lung cancer, remains a major contributor to cancer-related mortality worldwide. Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, has beenrepurposed as an anticancer agent for NSCLC therapy. In the present study, celecoxib-loaded Soluplus/zein composite nanoparticles coated with chitosan were successfully developed and evaluated as a promising pulmonary drug delivery system for NSCLC. The nanoparticles were prepared using an antisolvent precipitation technique and demonstrated favorable physicochemical properties. The optimized formulation exhibited a particle size of approximately 190 nm with high encapsulation efficiency (85.34%), and high drug-loading capacity (14.21%). The chitosan coating increased the zeta potential to nearly +30.42 mV, yielding enhanced stability and desirable mucoadhesive properties for pulmonary administration. In vitro release studies revealed sustained release under simulated physiological lung conditions, following diffusion- and swelling-controlled release mechanisms. Cytotoxicity evaluation using the MTT assay demonstrated significant anticancer activity against A549 lung cancer cells while maintaining good biocompatibility toward BEAS-2B normal human bronchial epithelial cells. The optimized nanoparticles also showed efficient transport across an air–liquid interface (ALI) airway epithelial barrier, with a Papp value of 4.15 × 10–4 cm·s–1 and 0.38% translocation after 24 h. Furthermore, aerosolized nanoparticles displayed excellent aerodynamic performance, with a fine particle fraction (FPF) of 68.51% and a mass median aerodynamic diameter (MMAD) of 3.93 μm using the Next Generation Impactor (NGI). Overall, these findings highlight the potential of celecoxib-loaded Soluplus/zein nanoparticles coated with chitosan as a promising pulmonary drug delivery system for NSCLC via nebulization.

21 November 2025 in Scientific Reports
Verified
Journal Article
Open access
STSuradwadee Thungmungmee
Suradwadee Thungmungmee
BSBoonchoo Sritularak
Boonchoo Sritularak
NWNakuntwalai Wisidsri
Nakuntwalai Wisidsri
NNNattika Nimmano
Nattika Nimmano
Skin aging is a complex process caused by oxidative stress, leading to a growing need for cosmeceuticals with effective antioxidant and matrix metalloproteinase-1 (MMP-1) inhibitory activities. D. formosum has shown various biological activities; however, an appropriate delivery system is required to enhance its efficacy. Our study firstly explored the protective effects of D. formosum extract on UVB-irradiated human keratinocytes (HaCaT) and human fibroblasts (BJ), and then developed topical microemulsion (ME) containing D. formosum extract. Our results show that D. formosum extract demonstrates anti-aging properties by reducing intracellular reactive oxygen species (ROS) in UVB-irradiated HaCaT and BJ, and inhibiting MMP-1 expression. Pseudo-ternary phase diagrams were constructed using the water titration method. The optimized microemulsion base (MEB) contained trilaureth-4 phosphate: propylene glycol (surfactant: cosurfactant; 2:1, 57.50%), isononyl isononanoate (oil, 17.50%), and deionized water (25.00%). The 0.40% w/w D. formosum extract, called DME1, was loaded into the MEB. This formulation exhibited desirable characteristics, including size, polydisperse index (PDI), zeta potential, and viscosity. DME1 was physicochemically and chemically stable. The DME1 also significantly increase skin retention and was safe to human skin cells. Our findings highlight D. formosum extract as a novel active ingredient and its potentially topical delivery for anti-aging purpose.

13 October 2026 in OpenNano
Verified
Journal Article
Open access
NLNandar Tint Lwin
Nandar Tint Lwin
Veerakiet BoonkanokwongVeerakiet Boonkanokwong
Veerakiet Boonkanokwong
WPWongsakorn Phongsopitanun
Wongsakorn Phongsopitanun
UJUngkarn Jarujareet
Ungkarn Jarujareet
PMPapon Muangsanit
Papon Muangsanit
NNNattika Nimmano
Nattika Nimmano